Difficulty: Medium
Average Score: 63%
Practice
What is the priority action for a newborn with a positive Coombs test?
Correct answer
B
Rationale
In the context of a newborn with a positive Coombs test, the priority action is to monitor for jaundice progression, which is option B. This is because a positive Coombs test indicates the presence of antibodies on the newborn's red blood cells, which can lead to hemolysis and subsequent jaundice. Monitoring for jaundice progression allows healthcare providers to assess the severity of the condition and determine if further interventions are needed.
Option A, beginning phototherapy immediately, is not the priority action because phototherapy is typically initiated based on the level of bilirubin in the newborn's blood, not solely on the basis of a positive Coombs test.
Option C, administering immunoglobulin therapy, is not the priority action for a positive Coombs test. While immunoglobulin therapy may be indicated in certain cases of hemolytic disease of the newborn, it is not the initial priority when managing a newborn with a positive Coombs test.
Option D, initiating exchange transfusion procedures, is a more invasive and aggressive intervention that is typically reserved for severe cases of hyperbilirubinemia that do not respond to other treatments. It is not the initial priority action when dealing with a positive Coombs test in a newborn.
In maternal newborn nursing, understanding the implications of a positive Coombs test and the appropriate interventions is crucial for providing safe and effective care to newborns at risk for hemolytic disease. Monitoring for jaundice progression allows for timely interventions and prevents complications associated with severe hyperbilirubinemia.
Option A, beginning phototherapy immediately, is not the priority action because phototherapy is typically initiated based on the level of bilirubin in the newborn's blood, not solely on the basis of a positive Coombs test.
Option C, administering immunoglobulin therapy, is not the priority action for a positive Coombs test. While immunoglobulin therapy may be indicated in certain cases of hemolytic disease of the newborn, it is not the initial priority when managing a newborn with a positive Coombs test.
Option D, initiating exchange transfusion procedures, is a more invasive and aggressive intervention that is typically reserved for severe cases of hyperbilirubinemia that do not respond to other treatments. It is not the initial priority action when dealing with a positive Coombs test in a newborn.
In maternal newborn nursing, understanding the implications of a positive Coombs test and the appropriate interventions is crucial for providing safe and effective care to newborns at risk for hemolytic disease. Monitoring for jaundice progression allows for timely interventions and prevents complications associated with severe hyperbilirubinemia.